news report
FDA Approves First Orexin-Targeting Drug for Narcolepsy Type 1
Orzeyful, or oveporexton, is the first approved medicine designed to restore the missing wakefulness signal behind the disorder’s full symptom pattern.
entities
Takeda Pharmaceuticals America